Substance

ID:1824214

Names and Identifiers
IUPAC name
(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
IUPAC Traditional name
pravastatin
Synonyms
pravastatin(+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acidpravastatin acid
International Nonproprietary Name (INN)
pravastatinpravastatinapravastatinepravastatinum
Registration numbers
PubChem CID
CAS Number
KEGG ID
KNApSAcK Database
LINCS Database
PubMed Citation Links
Reaxys Registry
ACToR Database
BKMS React Database
BRENDA Ligand Database
CompTox Database
SureChEMBL Database
UniProt Database
HMDB Database
Wikipedia Title
DrugBank ID
Drug Central Database
KEGG DRUG Database
PubChem SID
Properties
No Data Available
Click here to submit data
Molecule Details
A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data